| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/EDRV-11-2-266 |
| P698 | PubMed publication ID | 2114281 |
| P2093 | author name string | Clarke CL | |
| Sutherland RL | |||
| P433 | issue | 2 | |
| P304 | page(s) | 266-301 | |
| P577 | publication date | 1990-05-01 | |
| P1433 | published in | Endocrine Reviews | Q3054007 |
| P1476 | title | Progestin regulation of cellular proliferation | |
| P478 | volume | 11 |
| Q40804070 | 17beta-oestradiol stimulates capacitative Ca2+ entry in human endometrial cells. |
| Q28346596 | A complex role for the progesterone receptor in the response to vascular injury |
| Q40800520 | A risk-benefit appraisal of transdermal estradiol therapy |
| Q30370823 | ARID1A Is Essential for Endometrial Function during Early Pregnancy |
| Q33809166 | Aberrant Proliferation of Differentiating Alveolar Cells Induces Hyperplasia in Resting Mammary Glands of SV40-TAg Transgenic Mice |
| Q36619003 | Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women |
| Q43539817 | Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells |
| Q33888599 | Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor |
| Q43764725 | Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array |
| Q38312749 | Analysis of epidermal growth factor receptor mRNA expression by polymerase chain reaction assay in 94 human breast adenocarcinoma tumors |
| Q53267259 | Androgen receptor polymorphisms and endometrial cancer risk. |
| Q39351791 | Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors |
| Q40786675 | Apoptosis induced by progesterone in human ovarian cancer cell line SNU-840. |
| Q34861793 | Association of progesterone receptor polymorphism with idiopathic recurrent pregnancy loss in Taiwanese Han population |
| Q37144740 | Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer |
| Q37781475 | Breast cancer, stem cells and sex hormones. Part 2: The impact of the reproductive years and pregnancy |
| Q33793529 | CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis |
| Q24299412 | CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome |
| Q35745143 | Cell cycle genes in a mouse mammary hyperplasia model |
| Q44144559 | Changes in sex hormone receptors during administration of progesterone to prevent estrus in the bitch |
| Q33179401 | Characterization of a testicular 17alpha, 20beta-dihydroxy-4-pregnen-3-one (a spermiation-inducing steroid in fish) receptor from a teleost, Japanese eel (Anguilla japonica). |
| Q74115762 | Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers |
| Q48372674 | Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland |
| Q42663046 | Cloning, pharmacological characterization and expression analysis of Atlantic cod (Gadus morhua, L.) nuclear progesterone receptor. |
| Q35535618 | Contraceptive steroids and the mammary gland: is there a hazard?--Insights from animal studies |
| Q33962726 | Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells. |
| Q37100117 | Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer |
| Q43759022 | Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2. |
| Q34763271 | Cyclin G1 and cyclin G2 are expressed in the periimplantation mouse uterus in a cell-specific and progesterone-dependent manner: evidence for aberrant regulation with Hoxa-10 deficiency |
| Q73973164 | Cyclins and breast cancer |
| Q37244666 | DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast |
| Q43692628 | Detection of estrogen alpha and progesterone receptors and cell proliferation in the uterus during early pregnancy in the goat |
| Q74155860 | Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle |
| Q34430545 | Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line |
| Q74298667 | Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells |
| Q43818066 | Disruption of MSSP, c-myc single-strand binding protein, leads to embryonic lethality in some homozygous mice |
| Q33616773 | Distribution of estrogen and progesterone receptors isoforms in endometrial cancer |
| Q74132264 | Distribution of progesterone receptor in chicken: novel target organs for progesterone and estrogen action |
| Q34990893 | Divergent behavior of cyclin E and its low molecular weight isoforms to progesterone-induced growth inhibition in MCF-7 cells |
| Q35010135 | Divergent mechanisms for trophic actions of estrogens in the brain and peripheral tissues |
| Q55228669 | Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women. |
| Q42855689 | Down‐regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system |
| Q39584875 | E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex |
| Q33742326 | ERBB receptor feedback inhibitor 1 regulation of estrogen receptor activity is critical for uterine implantation in mice |
| Q46833575 | Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia |
| Q71989519 | Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma |
| Q44752742 | Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts |
| Q39581323 | Effects of different progestogens on human breast tumor cell growth |
| Q70926384 | Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques |
| Q31800367 | Effects of low-frequency magnetic fields on implantation in rats |
| Q50538085 | Effects of sex steroids on proliferation in normal mammary tissue. |
| Q85018019 | Effects of testosterone, estrogen and progesterone on TNF-α mediated cellular damage in rat arthritic synovial fibroblasts |
| Q30049057 | Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies |
| Q37381480 | Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial |
| Q33709986 | Estrogen action: a historic perspective on the implications of considering alternative approaches |
| Q33923687 | Estrogen and progestin regulation of cell cycle progression |
| Q40981868 | Estrogen causes cell death of estrogen receptor stably transfected cells via apoptosis |
| Q37094546 | Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland |
| Q93886960 | Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer |
| Q41142705 | Estrogen replacement therapy in survivors of breast cancer: a risk-benefit assessment |
| Q42445773 | Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression |
| Q33861541 | Estrogen with interrupted progestin HRT: a review of experimental and clinical studies |
| Q43954175 | Estrogen-alpha and progesterone receptor expression in cystic endometrial hyperplasia and pyometra in the bitch |
| Q31039079 | Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells |
| Q36067788 | Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis |
| Q70658141 | Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins |
| Q42816138 | Expression of progesterone receptor B is associated with G0/G1 arrest of the cell cycle and growth inhibition in NIH3T3 cells |
| Q36271239 | Expression of transcription factors in endometrium during natural cycles. |
| Q35671123 | Expression profiling of human breast cancers and gene regulation by progesterone receptors |
| Q43430168 | Flutamide influences placental aldo-keto reductase family 1 member C1 (AKR1C1) expression in pigs. |
| Q40973699 | G-protein coupled receptor 64 is required for decidualization of endometrial stromal cells |
| Q37699860 | Gene expression profiling of the paracrine effects of uterine natural killer cells on human endometrial epithelial cells |
| Q28660394 | Genome-wide association study of endometrial cancer in E2C2 |
| Q37056109 | Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. |
| Q34215127 | Growth hormone mRNA in mammary gland tumors of dogs and cats |
| Q52213712 | Growth hormone receptor gene expression in the mouse uterus: modulation by gonadal steroids. |
| Q41226072 | Growth inhibition by anti-estrogens and progestins in TGF-beta-resistant and -sensitive breast-tumor cells |
| Q24307837 | HDLG5/KIAA0583, encoding a MAGUK-family protein, is a primary progesterone target gene in breast cancer cells |
| Q33830916 | HRT and cancer risk: separating fact from fiction |
| Q34463159 | Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. |
| Q74072045 | Hormone replacement therapy and breast cancer |
| Q35115403 | Hormone replacement therapy and risk of breast cancer: the role of progestins |
| Q59074781 | Hormone replacement therapy and risk of breast cancer: the role of progestins |
| Q34638087 | Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters |
| Q44456211 | Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers |
| Q33867501 | Immunocytochemical localization of sex steroid hormone receptors in normal human mammary gland |
| Q45722920 | Immunolocalization of estrogen and progesterone receptors in ewe mammary glands. |
| Q34987316 | In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide |
| Q28731452 | Induction of overt menstruation in intact mice |
| Q38169799 | Influence of sex steroids on inflammation and bone metabolism |
| Q72629944 | Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo |
| Q67886425 | Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF |
| Q73830090 | Inhibition of proliferation of T47D human breast cancer cells: alterations in progesterone receptor and p53 tumor suppressor protein |
| Q53644114 | Inhibitory role of REV-ERBα in the expression of bone morphogenetic protein gene family in rat uterus endometrium stromal cells. |
| Q36245560 | Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim |
| Q51503275 | Interplay of nuclear receptors (ER, PR, and GR) and their steroid hormones in MCF-7 cells. |
| Q44033059 | Is mechanically induced cystic endometrial hyperplasia (CEH) a suitable model for study of spontaneously occurring CEH in the uterus of the bitch? |
| Q38456582 | Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis |
| Q35087360 | MTHFR (C677T) polymorphism and PR (PROGINS) mutation as genetic factors for preterm delivery, fetal death and low birth weight: A Northeast Indian population based study |
| Q73215078 | Mammographic and ultrasonographic study of changes in the breast related to HRT |
| Q43726024 | Mammographic density changes during different postmenopausal hormone replacement therapies |
| Q73959916 | Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor |
| Q34258303 | Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature |
| Q33993962 | Mechanisms of cyclin-dependent kinase inactivation by progestins |
| Q29615568 | Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities |
| Q24792264 | Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase |
| Q51290637 | Mig-6 Mouse Model of Endometrial Cancer. |
| Q37190151 | Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease |
| Q35706738 | Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling. |
| Q37577169 | Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells |
| Q40759266 | Molecular biology of breast carcinoma |
| Q33573334 | Molecular cloning and functional characterization of a zebrafish nuclear progesterone receptor |
| Q37166756 | Molecular mechanisms underlying progesterone-enhanced breast cancer cell migration |
| Q70705357 | Morphology of the rat uterus after long-term treatment with progesterone antagonists |
| Q61855113 | Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women |
| Q35622050 | New insights into estrogen receptor function in human breast cancer |
| Q47103005 | No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis. |
| Q40662417 | Non-genomic effects of progestins--inhibition of cell growth and increased intracellular levels of cyclic nucleotides |
| Q35910912 | Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes |
| Q40992275 | Novel mechanisms of antiprogestin action |
| Q34430039 | Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation |
| Q39491094 | Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer |
| Q46921316 | Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function |
| Q46510663 | Null mutation of Kruppel-like factor9/basic transcription element binding protein-1 alters peri-implantation uterine development in mice |
| Q26751149 | Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene |
| Q37631397 | Patterns of Apoptosis and Proliferation throughout the Biennial Reproductive Cycle of Viviparous Female Typhlonectes compressicauda (Amphibia, Gymnophiona) |
| Q40486142 | Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. |
| Q40551549 | Potential impact on breast cancer risk of circulating insulin-like growth factor I modifications induced by oral HRT in menopause. |
| Q41257978 | Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells |
| Q35859530 | Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice |
| Q28580010 | Presence, actions, and regulation of myostatin in rat uterus and myometrial cells |
| Q73179490 | Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat |
| Q44019538 | Priming effects of novel nonsteroidal progesterone receptor modulators CP8816 and CP8863 on the development of adenomyosis in the mouse uterus |
| Q36989871 | Profiling of circadian genes expressed in the uterus endometrial stromal cells of pregnant rats as revealed by DNA microarray coupled with RNA interference |
| Q90073087 | Progesterone and Breast Cancer |
| Q37778115 | Progesterone and reproduction in marsupials: A review |
| Q44750448 | Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound |
| Q44830455 | Progesterone prevents radiation-induced apoptosis in breast cancer cells. |
| Q37302376 | Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter. |
| Q37338412 | Progesterone receptor action in leiomyoma and endometrial cancer |
| Q44922040 | Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells. |
| Q73218670 | Progesterone receptor is not required for progesterone action in the rat corpus luteum of pregnancy |
| Q36621572 | Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies |
| Q50053097 | Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling. |
| Q34469025 | Progesterone receptor variants found in breast cells repress transcription by wild-type receptors |
| Q35097256 | Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis |
| Q36277982 | Progesterone regulates the proliferation of breast cancer cells - in vitro evidence |
| Q42454022 | Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300. |
| Q34821355 | Progesterone regulation of reproductive function through functionally distinct progesterone receptor isoforms |
| Q30582325 | Progesterone therapy increases free thyroxine levels--data from a randomized placebo-controlled 12-week hot flush trial |
| Q46419945 | Progesterone transfer among cohabitating female big brown bats (Eptesicus fuscus). |
| Q46190230 | Progesterone, but not estradiol, synchronizes circadian oscillator in the uterus endometrial stromal cells |
| Q34453154 | Progesterone-action in the decidual mesometrium of pregnancy |
| Q36234203 | Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin |
| Q43739718 | Progesterone-induced secretion of growth hormone, insulin-like growth factor I and prolactin by human breast cancer explants |
| Q73034834 | Progesterone-regulated determinants of stromal cell survival and death in uterine decidua are linked to protein kinase C activity |
| Q77849851 | Progestin modulation of c-fos and prolactin gene expression in the human endometrium |
| Q34129948 | Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells |
| Q38761522 | Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors |
| Q36735932 | Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes |
| Q33694958 | Progestins in the menopause |
| Q33836927 | Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells |
| Q34060157 | Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease |
| Q37175385 | Progestogens' effects and mechanisms for object recognition memory across the lifespan |
| Q37407105 | Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment. |
| Q92988516 | Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation |
| Q73047474 | Proliferation of breast epithelial cells in healthy women during the menstrual cycle |
| Q40662090 | Prolonged progestin treatment induces the promoter of CDK inhibitor p21 Cip1,Waf1 through activation of p53 in human breast and endometrial tumor cells |
| Q34236652 | Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities |
| Q35598642 | Regulation of human endometrial function: mechanisms relevant to uterine bleeding |
| Q31774219 | Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-alpha knockout mouse |
| Q80390603 | Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study |
| Q34290001 | Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice |
| Q42445189 | Retinoid receptors in rat vaginal and uterine epithelia: changes with ovarian steroids |
| Q37961734 | Role of epigenomics in ovarian and endometrial cancers |
| Q34095034 | Role of progesterone in endometrial cancer |
| Q33525526 | Role of progesterone receptor polymorphisms in the recurrent spontaneous abortions: Indian case |
| Q33902476 | Role of the androgen receptor in human breast cancer |
| Q34565492 | Roles of androgens in the development, growth, and carcinogenesis of the mammary gland |
| Q81066756 | Roles of estrogen and progesterone in normal mammary gland development insights from progesterone receptor null mutant mice and in situ localization of receptor |
| Q55297932 | Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. |
| Q34188038 | Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells |
| Q34439850 | Sex-specific modification of progesterone receptor expression by 17β-oestradiol in human cardiac tissues |
| Q37169201 | Short photoperiod-induced ovarian regression is mediated by apoptosis in Siberian hamsters (Phodopus sungorus). |
| Q34486859 | Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival |
| Q35745129 | Steroid receptors and cell cycle in normal mammary epithelium. |
| Q34204663 | Steroid receptors and metastatic potential in endometrial cancers |
| Q34631186 | Steroid receptors in human breast tumorigenesis and breast cancer progression |
| Q52223864 | Stimulatory and inhibitory regulation of DNA synthesis during spermatogenesis: studies in Squalus acanthias. |
| Q28586589 | Subfertility, uterine hypoplasia, and partial progesterone resistance in mice lacking the Kruppel-like factor 9/basic transcription element-binding protein-1 (Bteb1) gene |
| Q40039095 | TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways |
| Q34022004 | Temporomandibular joint bone tissue resorption in patients with early rheumatoid arthritis can be predicted by joint crepitus and plasma glutamate level |
| Q48103177 | Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis. |
| Q36672641 | The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells |
| Q49080533 | The antiovulatory potential of progesterone antagonists correlates with a down-regulation of progesterone receptors in the hypothalamus, pituitary and ovaries |
| Q41226823 | The breast and the menopause |
| Q39592732 | The endogenous progesterone metabolite, 5a-pregnane-3,20-dione, decreases cell-substrate attachment, adhesion plaques, vinculin expression, and polymerized F-actin in MCF-7 breast cancer cells |
| Q36597665 | The nuclear receptor REV-ERBα represses the transcription of growth/differentiation factor 10 and 15 genes in rat endometrium stromal cells |
| Q28397662 | The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer |
| Q24542480 | The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis |
| Q39339376 | The role of progesterone and its receptor on cyclin G1 expression in endometrial carcinoma cells |
| Q37350329 | Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium |
| Q35061924 | Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus |
| Q22010386 | Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity |
| Q28771752 | Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells |
| Q33997402 | Use of PRKO mice to study the role of progesterone in mammary gland development |
| Q40790191 | William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis |
| Q37708108 | cAMP-Response Element-Binding 3-Like Protein 1 (CREB3L1) is Required for Decidualization and its Expression is Decreased in Women with Endometriosis |
Search more.